Financials Genetec Corporation

Equities

4492

JP3428000008

IT Services & Consulting

Market Closed - Japan Exchange 02:00:00 2024-04-26 am EDT 5-day change 1st Jan Change
969 JPY -0.92% Intraday chart for Genetec Corporation +5.67% +77.47%

Valuation

Fiscal Period: März 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,997 3,470 3,269 3,450 11,037 - -
Enterprise Value (EV) 1 1,039 2,064 2,275 3,350 11,037 11,037 11,037
P/E ratio 9.46 x 19.9 x 57.5 x 145 x 63.6 x 50.5 x 43.6 x
Yield 0.26% 1.06% 1.37% 1.09% 0.86% 1.03% 1.2%
Capitalization / Revenue 0.42 x 0.85 x 0.7 x 0.59 x 1.71 x 1.62 x 1.53 x
EV / Revenue 0.42 x 0.85 x 0.7 x 0.59 x 1.71 x 1.62 x 1.53 x
EV / EBITDA - - - - - - -
EV / FCF 35,669,233 x 8,382,440 x -7,092,180 x -3,943,223 x - - -
FCF Yield 0% 0% -0% -0% - - -
Price to Book 1.47 x 1.9 x 1.76 x 1.86 x 5.61 x 5.27 x 4.99 x
Nbr of stocks (in thousands) 8,964 11,076 11,223 11,313 11,390 - -
Reference price 2 222.8 313.3 291.3 305.0 969.0 969.0 969.0
Announcement Date 5/28/20 5/14/21 5/16/22 5/15/23 - - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: März 2020 2021 2022 2023 2024 2025 2026
Net sales 1 4,720 4,079 4,683 5,864 6,460 6,833 7,209
EBITDA - - - - - - -
EBIT 1 335 254 190 105 329 399 456
Operating Margin 7.1% 6.23% 4.06% 1.79% 5.09% 5.84% 6.33%
Earnings before Tax (EBT) 327 276 117 87 - - -
Net income 1 212 173 56 23 173 218 252
Net margin 4.49% 4.24% 1.2% 0.39% 2.68% 3.19% 3.5%
EPS 2 23.54 15.77 5.063 2.100 15.23 19.20 22.20
Free Cash Flow 56 414 -461 -875 - - -
FCF margin 1.19% 10.15% -9.84% -14.92% - - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) 26.42% 239.31% - - - - -
Dividend per Share 2 0.5833 3.333 4.000 3.333 8.333 10.00 11.67
Announcement Date 5/28/20 5/14/21 5/16/22 5/15/23 - - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2021 S1 2022 S1 2022 Q3 2023 Q1 2023 S1 2023 Q3 2024 Q1 2024 S1 2024 Q3
Net sales 1 1,954 2,159 1,091 1,203 2,537 1,360 1,439 3,159 1,774
EBITDA - - - - - - - - -
EBIT 1 36 165 39 -175 -150 -48 -17 196 105
Operating Margin 1.84% 7.64% 3.57% -14.55% -5.91% -3.53% -1.18% 6.2% 5.92%
Earnings before Tax (EBT) 1 36 158 -4 -182 -177 -51 -20 197 112
Net income 1 23 86 -7 -131 -131 -50 -19 119 79
Net margin 1.18% 3.98% -0.64% -10.89% -5.16% -3.68% -1.32% 3.77% 4.45%
EPS 2 2.140 3.873 -0.6400 -11.68 -11.62 -4.480 -1.757 10.53 6.880
Dividend per Share - 0.6667 - - - - - 3.333 -
Announcement Date 11/5/20 11/15/21 2/14/22 8/10/22 11/14/22 2/14/23 8/10/23 11/14/23 2/14/24
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: March 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - -
Net Cash position 958 1,406 994 100 - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 56 414 -461 -875 - - -
ROE (net income / shareholders' equity) 16.5% 10% 3.1% 1.3% - - -
ROA (Net income/ Total Assets) - 9.97% 8.33% 3.01% - - -
Assets 1 - 1,735 672.1 764 - - -
Book Value Per Share 2 151.0 165.0 165.0 164.0 173.0 184.0 194.0
Cash Flow per Share 25.70 18.00 8.220 12.20 - - -
Capex 5 29 93.3 652 - - -
Capex / Sales 0.11% 0.71% 1.99% 11.12% - - -
Announcement Date 5/28/20 5/14/21 5/16/22 5/15/23 - - -
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
  1. Stock Market
  2. Equities
  3. 4492 Stock
  4. Financials Genetec Corporation